/Companies

Prolific Machines

Emeryville, US · Founded 2020 · Delaware corporation · 67 employees on LinkedIn · 14 known investors

Find your way into Prolific Machines

Sign up to see every warm intro you have to Prolific Machines

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Prolific Machines team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Prolific Machines licenses an optogenetics platform that adds light-based control to cell line development and GMP biomanufacturing, letting biopharma teams retrofit existing bioreactors and hosts to raise titers and manufacture complex molecule formats. It targets biopharmaceutical developers and manufacturers seeking higher productivity on difficult programs without re-platforming.

Founders & leadership

Prolific Machines was founded in 2020 by Maximilian Hörner, Max Huisman, Deniz Kent, Deniz Kent, Ph.D., and Declan Jones.

MHMaximilian Hörner
Maximilian HörnerFounder
MHMax Huisman
Max HuismanCo-Founder & CTOMax Huisman holds degrees in Applied Physics from the University of Delft and a PhD in Biomedical Sciences from the University of Massachusetts Medical School. He worked as a postdoctoral researcher at the RNA Therapeutics Institute at UMass Medical School before co-founding Prolific Machines, which develops an optogenetics platform for biopharmaceutical manufacturing.
DKDeniz Kent
Deniz KentFounder
DKDeniz Kent, Ph.D.
Deniz Kent, Ph.D.CEO & Co-FounderDeniz Kent holds a Ph.D. and founded Prolific Machines, which develops optogenetics platforms for cell line development and biopharmaceutical manufacturing.
DJDeclan Jones
Declan JonesCo-Founder & CIOCo-founder and Chief Data Officer of Prolific Machines, an optogenetics platform company for biopharmaceutical manufacturing. Previously a machine learning engineer at Zillow Group where he developed fraud prediction models; holds a B.A. in history and computer science from UC Berkeley with focus on computer graphics and image processing.
SMShahram Misaghi
Shahram MisaghiShahram Misaghi has spent over a decade in biological sciences research with publications in peer-reviewed journals, developing expertise in hybridoma production, high-throughput screening assays, protein expression and purification, and molecular cloning techniques.
CDChristelle Dagoneau
Christelle DagoneauChief Business Officer (Interim)Christelle Dagoneau brings 25+ years of experience in global leadership roles at biologics CDMOs, with expertise spanning bioprocessing strategy, business development, and strategic partnerships. She founded CD BioPartners to connect emerging bioprocessing technologies with commercial deployment opportunities in biopharma and biomanufacturing.
ERErik Riley
Erik RileyChief Financial Officer (Interim)
GHGeorge Hosegood
George HosegoodChief Operating Officer
LPLily Paloma
Lily PalomaVice President, PeopleShe has over a decade of experience in HR leadership at high-growth startups, including roles spanning early-stage development through IPO, with expertise in organizational development, talent acquisition, and people operations.
VJVictor Jones
Victor JonesChief Scientific Officer
VVVidar van der Meijdan
Vidar van der MeijdanVice President, Product

Investors · 14

Also in the syndicate · 4

BreakthroughEnergy VenturesConti VenturesKi Tua FundleadThe Ki Tua Fundlead

Funding

SEC filings, press & company announcements

$96.6M disclosed across 2 rounds · 2022–2024

▶$54.6MraisedMay 2024 · 36 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Arvind GuptaDirector
  • Campbell GrieveDirector
  • Max HuismanExecutive Officer, Director
  • Deniz KentExecutive Officer, Director
  • Cooper RinzlerDirector
Offering amount
$57.6M
Amount sold
$54.6M
First sale
May 2024
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Prolific Machines went on to found or lead other companies.

Related companies · 2

Companies working in the same space as Prolific Machines.

In the news

Frequently asked questions

What does Prolific Machines do?
Prolific Machines licenses an optogenetics platform that adds light-based control to cell line development and GMP biomanufacturing, letting biopharma teams retrofit existing bioreactors and hosts to raise titers and manufacture complex molecule formats. It targets biopharmaceutical developers and manufacturers seeking higher productivity on difficult programs without re-platforming.
Who founded Prolific Machines?
Prolific Machines was founded by Maximilian Hörner, Max Huisman, Deniz Kent, Deniz Kent, Ph.D., Declan Jones in 2020.
Who are Prolific Machines's investors?
Prolific Machines's investors include Baruch Future Ventures, Breakthrough Energy Ventures, Darco Capital, In-Q-Tel, Mayfield Fund, Solari Capital, SOSV, CPT Capital and 2 more.
How much funding has Prolific Machines raised?
Prolific Machines has disclosed $96.6M raised across 2 rounds.
Where is Prolific Machines headquartered?
Prolific Machines is headquartered in Emeryville, US.